Virtu Financial’s Beam Therapeutics BEAM Stock Holding History

Virtu Financial’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,486	Closed	-$875K	–	1320
2024 Q1	$875K	Buy	+26,486	New	+$825K	0.07%	250
2023 Q2	–	Sell	-7,804	Closed	-$239K	–	1518
2023 Q1	$239K	Buy	+7,804	New	+$308K	0.03%	652
2022 Q4	–	Sell	-10,267	Closed	-$489K	–	1614
2022 Q3	$489K	Buy	+10,267	New	+$586K	0.04%	411
2022 Q2	–	Sell	-7,909	Closed	-$453K	–	1588
2022 Q1	$453K	Buy	+7,909	New	+$519K	0.03%	427
2021 Q4	–	Sell	-3,624	Closed	-$315K	–	1714
2021 Q3	$315K	Buy	+3,624	New	+$364K	0.03%	690
2021 Q2	–	Sell	-22,256	Closed	-$1.78M	–	1521
2021 Q1	$1.78M	Buy	+22,256	New	+$2.12M	0.13%	122

Other funds holding BEAM

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Virtu Financial's BEAM Position: Q2 2024 in Review

Virtu Financial sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 26,486 shares — an estimated $875K sold.

Virtu Financial first reported a position in BEAM in Q1 2021 and held it in 6 quarters. The position peaked at $1.78M in Q1 2021. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.

Virtu Financial reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
Virtu Financial sold 26,486 Beam Therapeutics shares in Q2 2024, an estimated $875K.
Virtu Financial first reported a position in Beam Therapeutics in Q1 2021 and held it in 6 quarters.
Virtu Financial's Beam Therapeutics position peaked at $1.78M in Q1 2021.
214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.